U.S. Markets open in 2 hrs 35 mins

Love Amcoff Is The Employee Representative Director of Biotage AB (STO:BIOT) And They Just Spent kr125k On Shares

Simply Wall St

Even if it's not a huge purchase, we think it was good to see that Love Amcoff, the Employee Representative Director of Biotage AB (STO:BIOT) recently shelled out kr125k to buy stock, at kr125 per share. While we're hesitant to get too excited about a purchase of that size, we do note it increased their holding by a solid 45%.

View our latest analysis for Biotage

The Last 12 Months Of Insider Transactions At Biotage

While no particular insider transaction stood out, we can still look at the overall trading.

Biotage insiders may have bought shares in the last year, but they didn't sell any. You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

OM:BIOT Recent Insider Trading, January 5th 2020

Biotage is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership of Biotage

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. It appears that Biotage insiders own 3.9% of the company, worth about kr318m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

What Might The Insider Transactions At Biotage Tell Us?

It's certainly positive to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. When combined with notable insider ownership, these factors suggest Biotage insiders are well aligned, and quite possibly think the share price is too low. Looks promising! Of course, the future is what matters most. So if you are interested in Biotage, you should check out this free report on analyst forecasts for the company.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.